SABBA STEPHEN L sold 5.7% of their position (2.03K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $409.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2026ACC: 0001104659-26-023943
-2.03K
Net shares
Net seller
$409.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.03K acquired · 4.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.03K
Price / share
$69.51
Trade value
$141.38K
% of position
6.0%
3/3/2026
33.79K→35.83K
Common Stock
Direct
Shares
−2.03K
Price / share
$201.50
Trade value
$409.85K
% of position
5.7%
3/3/2026
35.83K→33.79K
Total
Net shares
+0.00
Net value
-$268.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2026 | M · Option Exercise | +2.03K | $69.51 | $141.38K | 6.0% | 33.79K | 35.83K |
| Common Stock Direct | 3/3/2026 | S · Sale | −2.03K | $201.50 | $409.85K | 5.7% | 35.83K | 33.79K |
| Total | +0.00 | -$268.47K | ||||||
Derivative Transactions1
Non- Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
2.03K shares
Shares
−2.03K
Strike price
69.51
Held after
0.00
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non- Qualified Stock Option (right to buy) Direct | Common Stock2.03K shares | 3/3/2026 | M · Option Exercise | −2.03K | 69.51 | — | 0.00 |